Panagiota Fotiadou

Panagiota Fotiadou started their work experience as a Chemist at Euromedica Group SA in June 2018, where they worked until September 2018. Following this, they joined Pharmathen in September 2021 as a Quality Control Junior Analyst, and their employment with the company lasted until August 2022. Currently, Panagiota is working as a Research and Development Analyst at DEMO Pharmaceuticals S.A. since September 2022.

Panagiota Fotiadou completed their Bachelor of Science (BS) degree in Chemistry at Aristotle University of Thessaloniki (AUTH) from 2014 to 2020. Following that, they pursued a Master of Science (MS) degree in Clinical and Industrial Pharmacology - Clinical Toxicology at the same institution from 2020 to 2023. In addition to their academic qualifications, Panagiota has obtained several certifications. Panagiota acquired the "Drug life cycle as a tool in drug policy analysis" certification from Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology in April 2023. In March 2021, they completed the "International Harmonisation Initiatives" certification from the same institution. Panagiota also obtained two certifications from Coursera: "Fundamentals of financial and management accounting" in February 2021 and "Drug Commercialization" in January 2021. Lastly, they hold the "ECDL Expert Certificate" from ICDL Europe, which was obtained in May 2011, and the "ECDL WebStarter Certificate" obtained in March 2011.